Investing.com - Constellium Nv (NYSE: CSTM) reported third quarter EPS of €0.28, €0.19 worse than the analyst estimate of €0.46. Revenue for the quarter came in at €1.72B versus the consensus estimate of €1.87B.
Constellium Nv's stock price closed at €16.28. It is down -14.27% in the last 3 months and up 32.91% in the last 12 months.
Constellium Nv saw 2 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Constellium Nv's stock price’s past reactions to earnings here.
According to InvestingPro, Constellium Nv's Financial Health score is "great performance".
Check out Constellium Nv's recent earnings performance, and Constellium Nv's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar